Speaker Presentations 

Wednesday, February 10, 2010

BENEFITS OF CONTINUOUS PERITONEAL INSULIN INFUSION DELIVERY AS PART OF AN OPEN AND CLOSED LOOP SYSTEM - WORKSHOP SPONSORED BY ROCHE DIABETES CARE

• DIAPORT-001 STUDY AND DIAPORT POST STUDY EXPERIENCE IN MONTPELLIER,   E. Renard, France
  
  
• THE NEW  PORT SYSTEM – WHAT IMPROVEMENTS CAN WE EXPECT?,  A. Skene, UK
  
  
• HOW INTRA-PERITONEAL INSULIN DELIVERY CHANGES THE LIFE OF A PATIENT WITH BRITTLE DIABETES, A. Liebl, Germany

 

Thursday, February 11, 2010

SESSON 1: FIGHTING GLUCOSE CONTROL IN PATIENTS WITH T2D

• HYPOGLYCAEMIA IN TYPE 2: WHAT IS THE PROBLEM?, S. Amiel, UK
  
  
• TYPE 2 DIABETES AND PUMP THERAPY -LECTURE SPONSORED BY ANIMAS CORPORATION, B. Bode, USA
  
  
• SGLT2 RECEPTOR BLOCKERS AND GLUCOKINASE ACTIVATORS, R. Henry, USA
  
  
• NEW LONG-ACTING INSULIN ANALOGS, P. Home, UK
  
  
• DISCOVERY AND DEVELOPMENT OF LIRAGLUTIDE, THE FIRST ONCE-DAILY HUMAN GLP-1 ANALOGUE - LECTURE SPONSORED BY NOVO NORDISK, L. Bjerre Knudsen, Denmark
  
  
• MULTI-HORMONAL TREATMENT OF OBESITY, J. Skyler, USA

• ---

SESSION 2: INDIVIDUALIZED DECISION SUPPORT FOR IMPROVEMENT OF DIABETES OUTCOME. SESSION SPONSORED BY ROCHE DIABETES CARE

• THE CURRENT STATE OF DECISION SUPPORT FOR PERSONALIZED DIABETES MANAGEMENT, S. Garg, USA
  
  
• INDIVIDUALIZED DIABETES MANAGEMENT CONCEPT FOR T2DM: STRUCTURED SMBG TO VISUALIZE AND ANALYZE GLUCOSE PATTERN TO FACILITATE DECISION MAKING,  O. Schnell, Germany
  
  
• EFFECTIVE MANAGEMENT OF POST-PRANDIAL HYPERGLYCEMIA BY A NOVEL, METER-BASED BOLUS ADVISOR, H. Zisser, USA

---

SESSION 3: HYPERGLYCEMIA IN THE HOSPITAL (AIDPIT)

• BLOOD GLUCOSE CONTROL IN THE ICU: STATE OF THE ART, G. Van den Berghe, Belgium
  
  
• GLUCOSE INTERVENTIONS AT THE CORONARY CARE UNIT,  M. Kosiborod, USA
  
  
• HYPOGLYCAEMIA AND GLUCOSE VARIABILITY IN THE INTENSIVE CARE UNIT - DO THEY HURT? J.H. DeVries, The Netherlands

---

SESSION 4A: ORAL PRESENTATIONS

• CLOSED-LOOP INSULIN DELIVERY: CROSS-OVER RANDOMISED OVERNIGHT STUDY IN ADULTS WITH TYPE 1 DIABETES (T1D), R. Hovorka
  
  
• FEASIBILITY TO CONTROL POSTPRANDIAL GLYCAEMIC EXCURSIONS USING A CLOSED-LOOP FORMAT IN DIABETES TYPE 1, A PILOT STUDY, A. van Bon, J. Hermanides, R. Koops, J. Hoekstra, H. de Vries, The Netherlands
  
  
• HYPOGLYCEMIA DETECTION CAPABILITIES OF A MULTISENSOR DEVICE FOR NON-INVASIVE CONTINUOUS GLUCOSE MONITORING UNDER HOME-USE CONDITIONS, M. Talary, M. Mueller, L. Falco, O. De Feo, W. Stahel, A. Caduff, Switzerland
  
  
• THE CONTINUOUS NONINVASIVE MONITORING OF GLUCOSE BY ANTENNAE BASED DIELECTRIC SPECTROSCOPY , N. Axelrod, J. Schreiber, A. Lichtenstein, N. Ferera, A. Konevsky, Israel, Switzerland
  
  
• ZONE MODEL PREDICTIVE CONTROL WITH INSULIN MEMORY: A NEW APPROACH IN DIABETES CONTROL, B. Grosman, E. Dassau, H. Zisser, L. Jovanovič, F.J. Doyle III, USA
  
  
• DEVELOPMENT OF A SURFACE PLASMON RESONANCE BIOSENSING PROBE FOR PLASMA GLUCOSE, H. Nakamura, M. Seki, T. Akimoto, Japan
  
  
• A 12 HOUR FEASIBILITY STUDY OF CONTINUOUS GLUCOSE MONITORING USING GLUCOSE BINDING PROTEIN (GBP), K. Judge, L. Morrow, A. Lastovich, D. Kurisko, S. Keith, J. Hartsell, B. Roberts, E. Mcvey, K. Win, M. Hompesch, USA
  
  
• TRANSIT COMPARTMENT MODEL EFFECTIVELY CHARACTERIZES INSULIN ABSORPTION AND PHARMACOKINETIC PROFILES FOLLOWING SUBCUTANEOUS INJECTION WITH TWO KEY PARAMETERS, J. Shen, A. Oh, B. Sugarman, D. Muchmore, R. Bowsher, D. Vaughn, USA

---

SESSION 4B: ORAL PRESENTATIONS

• 'BENDING THE RULES´ - FREQUENT MALADAPTIVE BEHAVIOURS LIMIT THE EFFICACY OF CSII IN YOUTH,  M. O'Connell, S. Donath, F. Cameron, Australia
  
  
• “DIABETES INTERACTIVE DIARY” (DID): A RANDOMIZED MULTICENTER TRIAL ON A NEW TELEMEDICINE SYSTEM ENABLING FLEXIBLE DIET AND INSULIN THERAPY, M. Rossi, A. Nicolucci, P. Di Bartolo, D. Bruttomesso, A. Girelli, F.J. Ampudia, D. Kerr, A. Ceriello, C. De La Questa Mayor, F. Pellegrini, D. Horwitz, G. Vespasiani, Italy, Spain, UK, Spain, USA
  
  
• TELEMEDICINE SYSTEM IMPROVES GENERAL PRACTITIONERS CARE IN PATIENTS WITH DIABETES,  M.M. Bujnowska-Fedak, E. Puchala, A. Steciwko, Poland
  
  
• ENCAPSULATION TECHNOLOGY FOR DIABETES CELL THERAPY: HUMAN BETA-CELL FUNCTIONAL STUDIES AND PRIMATE PRECLINICAL TRIAL, P. Itkin-Ansari, USA
  
  
• MODELLING THE EFFECTS OF SINGLE AND COMBINATION ORAL THERAPIES IN PATIENTS WITH TYPE 2 DIABETES USING IHOMA, N. Hill, J. Wragg, D. Matthews, J. Levy, UK
  
  
• INTRODUCING THE TANTALUS^® (GASTRIC ELECTRICAL STIMULATION) IN T2DM SUBJECTS WITH BMI LOWER THAN 35 KG/M^2,  F. Papadia, N. Scopinaro, Italy
  
  
• ELECTRONIC HEALTH TECHNOLOGY FOR ASSESSMENT OF PHYSICAL ACTIVITY AND EATING HABITS IN CHILDREN AND ADOLESCENTS WITH OVERWEIGHT AND OBESITY, A. Kaps, G. Bieber, R. Schiel, Germany
  
  
• ASSESSMENT OF ORAL INSULIN FORMULATIONS IN HEALTHY MALE VOLUNTEERS - SAFETY AND PHARMACODYNAMIC COMPARISONS, M. Kidron, S. Samann, R. Freier, R. Eldor, E. Arbit, Israel, Switzerland
  
  
• PHARMACODYNAMIC AND PHARMACOKINETIC ANALYSIS OF MICRO-NEEDLE BASED INTRADERMAL INSULIN DELIVERY USING A BIPHASIC MODEL, M.D. Breton, A. Chan, S. Keith, R.J. Pettis, B.P. Kovatchev, L. Heinemann, USA, Germany
  
  
• HOME USE OF A PDA-PHONE ALLOWS A SIGNIFICANTLY BETTER GLUCOSE CONTROL IN TYPE 1 DIABETES: THE RANDOMIZED 6-MONTH TELEDIAB-1 STUDY, E. Renard, A. Farret, A. Penfornis, G. Charpentier, P.Y. Benhamou, P. Schaepelynck, B. Catargi, H. Hanaire, L. Chaillous, TeleDiab-1 Study Group,  France
  
  
• COMBINING BASAL-BOLUS INSULIN INFUSION FOR TIGHT POSTPRANDIAL GLUCOSE CONTROL. AN IN SILICO VALIDATION IN ADULTS, CHILDREN AND ADOLESCENTS,  A. Revert, R. Calm, J. Vehí, J. Bondia, Spain
  
  
• GLUCOMEN®DAY CONTINUOUS GLUCOSE MONITOR: FURTHER CLINICAL ASSESSMENT OF POINT AND TREND ACCURACY ACCORDING TO THE POCT05-A CLSI GUIDELINE, F. Valgimigli, F. Lucarelli, C. Scuffi, Italy
  
  
• ENDOGENOUS INSULIN DELIVERY FROM A NOVEL PORCINE PANCREATIC ISLET IMPLANT WITHOUT IMMUNOSUPPRESSION, P.L.J. Tan, R.B. Elliott, O. Garkavenko, K. Durbin, New Zealand, Australia
  
  
• REAL TIME MEDICATION MONITORING WITH REMINDERS PER TEXT MESSAGE IMPROVES ADHERENCE TO ORAL ANTIDIABETIC MEDICATION IN DIABETES TYPE 2 PATIENTS, M. Vervloet, L. van Dijk, J. Santen-Reestman, D.H. de Bakker, M.L. Bouvy, The Netherlands
  
  
• DIABEO: AN INNOVATIVE SYSTEM FOR THE FOLLOW-UP OF TYPE 2 DIABETIC PATIENTS, S. Franc, D. Dardari, A. Daoudi, H. Laroye, B. Boucherie, P. Leurent, P.-Y. Benhamou, Y. Reznik, G. Charpentier, France
  
  
• RESULTS OF THE EUROPEAN PAEDIATRIC ONSET STUDY EVALUATING SENSOR-ENHANCED CSII IN THE FIRST YEAR OF TYPE 1 DIABETES (T1D), O. Kordonouri, E. Pankowska, B. Rami, T. Kapellen, R. Coutant, R. Hartmann, A. Szypowska, K. Lange, T. Danne, Germany, Poland, Austria, Germany, France
  
  
• DUODENAL ELETCRICAL STIMULATION FOR THE TREATMENT OF TYPE 2 DIABETES - PRELIMINARY SAFTY AND EFFICACY RESULTS IN HUMAN , J. Aberle, P. Busch, O. Mann, R. Khawaled, J. Benarie, J.R. Izbicki, Germany, Israel

• ---

SESSION 5A: CONTINUOUS GLUCOSE SENSING: BEYOND EXPECTATIONS SESSION SPONSORED BY DEXCOM INC.

• CLINICAL APPLICATIONS:  CGM USE IN MDI, TYPE 2 AND ELDERLY PATIENTS, S. Garg, USA
  
  
• REDUCING GLYCEMIC VARIABILITY IN CHILDREN WITH THE DEXCOM SEVEN PLUS”, T. Danne, Germany
  
  
• DEXCOM IV CGM HOSPITAL DATA FROM THE UK EXPERIENCE: OPPORTUNITIES TO IMPROVE PATIENT CARE, N. Scawn, UK
  
  
• GIVE A GPS TO YOUR PATIENTS: REALITY EXCEEDS EXPECTATIONS, D. Cairns, UK

 

Friday, February 12, 2010

SESSION 6: CLOSING THE LOOP - 1

• ONLINE PREDICTION OF FORTHCOMING GLUCOSE PROFILE AND OUTCOMES FOR ADVICE ON INSULIN THERAPY: THE DIADVISOR CONCEPT, E. Renard, France
  
  
• DESIGN, VALIDATION AND CLINICAL EVALUATION OF A FULLY AUTOMATED ARTIFICIAL PANCREATIC Β-CELL WITH UNANNOUNCED MEAL USING MPMPC AND IOB, E. Dassau, H. Zisser, M.W. Percival, B. Grosman, L. Jovanovič, F.J. Doyle III, USA
  
  
• AUTOMATIC LEARNING ALGORITHM FOR THE MD-LOGIC ARTIFICIAL PANCREAS SYSTEM, S. Miller, E. Atlas, R. Nimri, E.A. Grunberg, M. Phillip, Israel
  
  
• MODULAR MODEL PREDICTIVE CLOSED-LOOP CONTROL OF DIABETES: PILOT STUDIES AND FUTURE DEVELOPMENTS, C. Cobelli, B. Kovatchev, Italy, USA
  
  
• CONTINUOUS GLUCOSE MONITOR CONSIDERATIONS IN AN ARTIFICIAL PANCREAS: AN FDA PERSPECTIVE, A. Pinkos, USA

 

SESSION 7: NEW APPLICATIONS & ADVANCES IN TECHNOLOGY FOR DIABETES - SESSION SPONSORED BY MEDTRONIC DIABETES

• TECHNOLOGY IN UNDERSERVED PATIENT POPULATION: MORE THAN OPTIMISATION OF METABOLIC CONTROL, P. Pozzilli, Italy
  
  
• CLINICAL APPLICATION OF PROFESSIONAL CGM, O. Cohen, Israel
  
  
• THE EXPENDING ROLE OF DATA MANAGEMENT, G. Cohen, USA

---

SESSION 8: PRANDIAL INSULIN THERAPY: OPTIONS FOR OPTIMIZATION (AIDPIT)

• CLINICAL FINDINGS FOR PATIENTS TREATED WITH VIAJECT^®, AN ULTRA-RAPID ACTING FORMULATION OF RECOMBINANT HUMAN INSULIN, S. Steiner, USA
  
  
• AN INHALED INSULIN WITH AN ULTRA-RAPID ONSET OF ACTION,  A. Boss, W. Yu, USA
  
  
•  LOCAL HEATING OF INSULIN APPLICATION SITE LED TO MORE RAPID ONSET OF INSULIN ACTION, R. Nagar, Israel
  
  
• ORAL INSULIN ON ITS RISE FOR PRANDIAL INSULIN THERAPY,  H. Iyer, India
  
  
• IMPROVEMENT IN INSULIN ABSORPTION PROPERTIES LEADS TOWARDS REDUCED POSTPRANDIAL GLYCAEMIC EXCURSIONS,  D. Muchmore, D. Vaughn, USA

---

SESSION 9: NON-INVASIVE GLUCOSE MONITORING: IS THERE ANYTHING NEW? SESSION SPONSORED BY AIMEDICS, INTEGRITY APPLICATIONS, RSP SYSTEMS, SENSILE MEDICAL & SOLIANIS MONITORING

• HYPOGLYCAEMIA DETECTION USING AUTONOMIC NERVOUS SYSTEM RESPONSES, V. Skladnev, Australia
  
  
• UNDERLYING MECHANISMS FOR NON INVASIVE GLUCOSE MONITORING USING A MULTISENSOR CONCEPT - WHAT DO WE KNOW TODAY?, A. Caduff, Switzerland
  
  
• COMBINING THREE TECHNOLOGIES AND MULTI SENSORS: AN ALTERNATIVE APPROACH TO INCREASE ACCURACY IN NON-INVASIVE GLUCOSE MEASUREMENTS, A. Raykhman, USA
  
  
• TOWARDS UNIVERSALLY CALIBRATED RAMAN BGM,  A. Weber, Denmark
  
  
• PROVOKING GLUCOSE EXCURSIONS IN TYPE 1 DIABETIC SUBJECTS: A POSSIBLE STANDARD TO EVALUATE THE CLINICAL PERFORMANCE OF CONTINUOUS GLUCOSE SENSORS, G. Freckmann, D. Brandt, Germany, Switzerland

---

SESSION 10: MODERN BGM TECHNOLOGY: SIMPLIFYING DIABETES SELF-MANAGEMENT - SESSION SPONSORED BY BAYER CONSUMER CARE AG DIABETES CARE

• EDUCATING RITA: SMBG AS AN EDUCATIONAL TOOL, A. Felton, UK
  
  
• WHAT'S IT ALL ABOUT, ALFIE? ACCURACY BEYOND THE LAB, I. Hirsch, USA
  
  
• GUESS WHO'S COMING TO DINNER? THE IMPORTANCE OF PPG, A. Ceriello, Spain
  
  
• THE GOOD, THE BAD AND THE UGLY: A CASE DISCUSSION OF PATTERN MANAGEMENT USING TECHNOLOGY, A. Ceriello,  A. Felton,  I. Hirsch, Spain, UK, USA

 

Saturday, February 13, 2010

SESSION 11: ATTD 2009 YEARBOOK

• SELF BLOOD GLUCOSE MONITORING (SBGM), S. Garg, USA
  
  
• CONTINUOUS GLUCOSE SENSORS, B. Bode, USA
  
  
• PUMPS, J. Pickup, UK
  
  
• CLOSING THE LOOP, E. Dassau, USA
  
  
• NEW INSULINS, T. Danne, Germany
  
  
• NEW WAYS OF INSULIN DELIVERY, L. Heinemann, Germany
  
  
• INTERNET AND IT USE IN TREATMENT OF DIABETES, N. Kaufman, USA
  
  
• TECHNOLOGY AND PREGNANCY, M. Hod, Israel
  
  
• IMMUNOMODULATION (IMMUNOTHERAPY) FOR TYPE 1 DIABETES MELLITUS, J. Skyler, USA
  
  
• EXERCISE AND DIABETES,  H. Zisser, USA

---

SESSION 12: GLUCOSE MANAGEMENT IN THE HOSPITAL

• THE IMPORTANCE OF GLUCOSE CONTROL IN THE ICU: WHERE FROM AND WHERE TO GO,  M. Ellmerer, Austria
  
  
• USE OF REAL-TIME CONTINUOUS GLUCOSE MONITORING IN A MEDICAL INTENSIVE CARE UNIT: PRELIMINARY RESULTS. LECTURE SPONSORED BY A.MENARINI DIAGNOSTICS, C. De Block, Belgium
  
  
• BEST USE OF DIABETES TECHNOLOGY FOR GLUCOSE MANAGEMENT IN THE HOSPITAL, I. Hirsch, USA
  
  
• GLYCEMIC CONTROL IN THE HOSPITAL: WHAT IS THE TARGET AND WHAT IS THE BEST METHODOLOGY, B. Bode, USA

---

SESSION 13: CLOSING THE LOOP - 2

• IS CSII MORE EFFECTIVE IN SOME PATIENTS THAN OTHERS?,  J. Pickup, UK
  
  
• CONTINUOUS GLUCOSE MONITOR (CGM) USE IN CHILDREN WITH TYPE 1 DIABETES (T1D), H.P. Chase, B. Buckingham, USA
  
  
• EFFECT OF RT-CGM ON HYPOGLYCEMIA IN PATIENTS WITH WELL-CONTROLLED TYPE 1 DIABETES, T. Battelino, Slovenia

 

• EXCITATION: THE USE OF FLUORESCENCE IN GLUCOSE MONITORING (PART 1)
  H. Zisser, USA

 

 

• EXCITATION: THE USE OF FLUORESCENCE IN GLUCOSE MONITORING (PART 1)
  T. Peyser, USA

 

---

SESSION 14A: DIABETES IN PREGNANCY

• RECOMMENDATIONS ON THE DIAGNOSIS AND CLASSIFICATION OF HYPERGLYCEMIA IN PREGNANCY, M. Hod, Israel
  
  
• UTILITY OF CONTINUOUS GLUCOSE MONITORING THROUGHOUT PREGNANCIES COMPLICATED BY DIABETES MELLITUS, L. Jovanovic, USA
  
  
• HOW TO DEFINE A WELL CONTROLLED DIABETES DURING PREGNANCY?, Y. Yogev, Israel

---

SESSION 14B: HUMAN & TECHNOLOGY

• SWEET: IT SOLUTIONS FOR INTERNATIONAL QUALITY CONTROL AND PATIENT CARE , T. Danne, Germany
  
  
• PATIENT SELF-MANAGEMENT SUPPORT: HOW THE INTERNET CAN BE USED TO MAKE EFFECTIVE PROGRAMS AFFORDABLE, N. Kaufman, USA
  
  
• REAL-LIFE UTILIZATION OF REAL-TIME CONTINUOUS GLUCOSE MONITORING - THE COMPLETE PICTURE, N. Ramchandani, USA

• ---

SESSION 15

• STEM CELL THERAPY FOR DIABETES: HOW CLOSE ARE WE?, P. Jones, UK
  
  
• IMMUNE INTERVENTION IN T1D, J. Skyler, USA